美国三个病人使用“人民的希望”的情况

“Based on our review of the clinical and virological courses, we believe remdesivir’s contribution to efficacy remains unclear, and with a side-effect profile that may not be completely benign,” the RBC analysts wrote in a note to investors. “We continue to see a less than 50/50 possibility that the drug is ultimately proven effective.”

https://www.statnews.com/pharmalot/2020/03/13/gilead-coronavirus-covid19-clinical-trials/

 

所有跟帖： 

• statenews 的新闻观点不能全信，尤其关于新药。华尔街的分析家更不可靠 -nowayitsover- ♂ (0 bytes) () 03/14/2020 postreply 22:10:32

• 链接里有原始论文，值得一读 -吃与活- ♂ (0 bytes) () 03/15/2020 postreply 06:00:29

• 我觉得应该在轻型患者中多找人做controlled trial. 病重的就一律都给吧，反正现在没有什么好办法 -viewfinder- ♀ (0 bytes) () 03/15/2020 postreply 04:04:02